HONG KONG, Germantown, Md. and SUZHOU, China, July 12, 2023 /PRNewswire/ — Sirnaomics Ltd. (the “Company”, stock code: 2257, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, hereby announces that Sirnaomics’ Senior Director of Technology Innovation, Dr.…Read More
Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences
